U.S. FDA moves to remove versions of heartburn drug Zantac from market
8:03am PDT - April 1st, 2020 zantac - ReutersThe U.S. Food and Drug Administration said on Wednesday it was requesting makers of all versions of heartburn drug Zantac to remove the drugs from the market immediately due to the presence of a probable carcinogen.